abacavir

Generic: abacavir

Labeler: avpak
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name abacavir
Generic Name abacavir
Labeler avpak
Dosage Form TABLET
Routes
ORAL
Active Ingredients

abacavir sulfate 300 mg/1

Manufacturer
AvPAK

Identifiers & Regulatory

Product NDC 50268-049
Product ID 50268-049_47e2137a-9afb-1285-e063-6294a90a4979
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091560
Listing Expiration 2027-12-31
Marketing Start 2020-04-10

Pharmacologic Class

Classes
cytochrome p450 1a1 inhibitors [moa] human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc] nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50268049
Hyphenated Format 50268-049

Supplemental Identifiers

RxCUI
242679
UNII
J220T4J9Q2

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name abacavir (source: ndc)
Generic Name abacavir (source: ndc)
Application Number ANDA091560 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 20 BLISTER PACK in 1 BOX (50268-049-12) / 1 TABLET in 1 BLISTER PACK (50268-049-11)
source: ndc

Packages (1)

50268-049-12 20 BLISTER PACK in 1 BOX (50268-049-12) / 1 TABLET in 1 BLISTER PACK (50268-049-11)

Ingredients (1)

abacavir sulfate (300 mg/1)

Linked Drug Pages (1)

Abacavir ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "47e2137a-9afb-1285-e063-6294a90a4979", "openfda": {"unii": ["J220T4J9Q2"], "rxcui": ["242679"], "spl_set_id": ["a2f06528-f3c5-2466-e053-2995a90ae18a"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "20 BLISTER PACK in 1 BOX (50268-049-12)  / 1 TABLET in 1 BLISTER PACK (50268-049-11)", "package_ndc": "50268-049-12", "marketing_start_date": "20200410"}], "brand_name": "Abacavir", "product_id": "50268-049_47e2137a-9afb-1285-e063-6294a90a4979", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A1 Inhibitors [MoA]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "50268-049", "generic_name": "Abacavir", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Abacavir", "active_ingredients": [{"name": "ABACAVIR SULFATE", "strength": "300 mg/1"}], "application_number": "ANDA091560", "marketing_category": "ANDA", "marketing_start_date": "20200410", "listing_expiration_date": "20271231"}